| CAS: | 940310-85-0 | ||
| 分子式: | C26H20F3N7O | ||
| 分子量: | 503.48 | ||
| 英文名称: |
| ||
| 用途: | NVP-BHG712是EphB4抑制剂,ED50为25 nM,对c-Raf,c-Src和c-Abl的IC50分别为0.395 μM,1.266 μM和1.667 μM。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||||||||||
| N796327 | MACKLIN | NVP-BHG712 | 10mM in DMSO | 795元/1ml; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| N864524 | MACKLIN | NVP-BHG712 | ≥98% | 495元/5mg; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| N1099 | TCI | NVP-BHG 712 | >95.0%(HPLC) | 990元/10MG; 3450元/50MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1239106 | J&K | NVP-BHG712 | 99%, 是受体酪氨酸激酶ephb4(ed50=25nm)的一种非常有效的选择性吸入剂 | 1189元/5MG; 2240元/10MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
产品描述 NVP-BHG712是一种特异性的EphB4抑制剂,ED50为25 nM,区别于对VEGFR和EphB4的抑制,对c-Raf, c-Src和c-Abl也具有抑制活性,IC50分别为0.395 μM, 1.266 μM和1.667 μM。 靶点(IC50 & Targe) c-Abl,1.667μM C-Raf,0.395μM c-Src,1.266μM EphB4,25nM(ED50) Tie-2,>10μM 体外研究 NVP-BHG712作用于稳定转染的A375黑色素瘤细胞,也抑制RTK自磷酸化,这种作用存在剂量依赖性,作用于EphB4和VEGFR2时, EC50分别为25 nM和 4.2 μM。 [1] 体内研究 NVP-BHG712 按3 mg/kg剂量口服给药生长因子诱导血管生成的模型,通过抑制EphB4前进信号,显著抑制VEGF刺激的组织和血管形成。而且, NVP-BHG712按10 mg/kg/kg剂量口服处理,有效逆转VEGF增强的组织形成和血管生长。NVP-BHG712 按3 mg/kg剂量口服处理小鼠,浓度约为10 μM,长期处理血浆及肺和肝脏组织,处理高达8小时,导致EphB4激酶活性长期受抑制。[1] 动物实验 Animal Models: 植入生长因子诱导VEGF调节血管生长的小鼠模型 Formulation: NVP-BHG712溶于1-甲基-2-吡咯烷酮(NMP),然后使用PEG-300稀释,终浓度为10% v/v NMP和 90% v/v PEG300 Dosages: ≤30 mg/kg Administration: 口服处理 (Only for Reference) 参考文献 [1] Martiny-Baron G, et al. Angiogenesis. 2010, 13(3), 259-267. 安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| SML0333 | Sigma-Aldrich | NVP-BHG712 | ≥98% (HPLC) | 1480.38元/5 MG; 5967.79元/25 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 应用 NVP-BHG712 has been used as an epinephrine type-B receptor 4 (Eph-B4) inhibitor:
NVP-BHG712 has been used as an ephrin type-B receptor 4 (Eph-B4) inhibitor to study its effect on Eph-B4 phosphorylation in ephrin-B2/Fc stimulated mouse lung endothelial cells. 包装 5, 25 mg in glass bottle 生化/生理作用 NVP-BHG712 is a very potent, selective inhbitor of the receptor tyrosine kinase EphB4 (ED50 = 25 nM). NVP-BHG712 blocks Ephrin receptor autophosphorylation and VEGF-induced angiogenesis. 特点和优势 This compound is a featured product for Kinase Phosphatase Biology research. Click here to discover more featured Kinase Phosphatase Biology products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||